FDA Indicates Move Towards Voluntary IRB Accreditation System
This article was originally published in The Gray Sheet
Executive Summary
FDA is expected to implement an institutional review board accreditation system that is voluntary and independent of the agency, but still under its jurisdiction, according to David Lepay, MD/PhD, acting director of the agency's Office of Clinical Science.